Isolation and identification of cyclic lipopeptides from Paenibacillus ehimensis, strain IB-X-b

J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Dec 15:973C:9-16. doi: 10.1016/j.jchromb.2014.09.042. Epub 2014 Oct 8.

Abstract

Antifungal lipopeptides produced by an antagonistic bacterium, Paenibacillus ehimensis strain IB-X-b, were purified and analyzed. The acetone extract of the culture supernatant contained an antifungal amphiphilic fraction stainable with ninhydrin on thin layer chromatography. The fraction was further purified with water-methanol extraction followed by a chromatography on a C18-support. The analysis with LC-MS showed presence of two main series of homologous compounds, family of depsipeptides containing a hydroxy fatty acid, three 2,4-diaminobutyric acid (Dab) residues, five hydrophobic amino acids and one Ser/Thr residue, and cyclic lipopeptides of bacillomycin L and fengycin/plipastatin/agrastatin families. The prevailing compounds in this group are bacillomycin L-C15, fengycin/plipastatin A-C16 together with their homologues responsible for the majority of fungal growth inhibition by P. ehimensis IB-X-b.

Keywords: Antifungal compounds; Biocontrol; Cyclic lipopeptides; LC–MS; Microbial antagonism; Paenibacillus ehimensis; Purification.